Patterson C. World Alzheimer Report 2018-the state of the art of dementia research: new frontiers. Alzheimer’s Dis Int. 2018:1–48.
Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. Alzheimers Dement. 2019;15(3):321–87.
Article
Google Scholar
Forner S, Baglietto-Vargas D, Martini AC, Trujillo-Estrada L, LaFerla FM. Synaptic impairment in Alzheimer’s disease: a dysregulated symphony. Trends Neurosci. 2017;40(6):347–57.
Article
CAS
PubMed
Google Scholar
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.
Article
CAS
PubMed
Google Scholar
Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–41.
Article
CAS
PubMed
Google Scholar
De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 1998;391(6665):387–90.
Article
PubMed
CAS
Google Scholar
Xin SH, Tan L, Cao X, Yu JT, Tan L. Clearance of amyloid beta and tau in Alzheimer’s disease: from mechanisms to therapy. Neurotox Res. 2018;34(3):733–48.
Article
CAS
PubMed
Google Scholar
Nalivaeva NN, Turner AJ. Targeting amyloid clearance in Alzheimer’s disease as a therapeutic strategy. Br J Pharmacol. 2019;176(18):3447–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for β-amyloid that mediates microglial function. Neuron. 2018;97(5):1023–31.e7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Talevi A, Bellera CL. Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics. Expert Opin Drug Discov. 2020;15(4):397–401.
Article
PubMed
Google Scholar
Tsuji N, Kobayashi M, Nagashima K, Wakisaka Y, Koizumi K. A new antifungal antibiotic, trichostatin. J Antibiot (Tokyo). 1976;29(1):1–6.
Article
CAS
Google Scholar
Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001;7(4):971–6.
CAS
PubMed
Google Scholar
Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002;1(4):287–99.
Article
CAS
PubMed
Google Scholar
Francis YI, Fa M, Ashraf H, Zhang H, Staniszewski A, Latchman DS, et al. Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer’s disease. J Alzheimers Dis. 2009;18(1):131–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang W, Chauhan A, Mehta S, Mehta P, Gu F, Chauhan V. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer’s disease. Life Sci. 2014;99(1–2):31–6.
Article
CAS
PubMed
Google Scholar
Yang W, Chauhan A, Wegiel J, Kuchna I, Gu F, Chauhan V. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer’s disease. Curr Alzheimer Res. 2014;11(10):1002–11.
Article
CAS
PubMed
Google Scholar
Li LH, Peng WN, Deng Y, Li JJ, Tian XR. Action of trichostatin A on Alzheimer’s disease-like pathological changes in SH-SY5Y neuroblastoma cells. Neural Regen Res. 2020;15(2):293–301.
Article
PubMed
Google Scholar
Leger M, Quiedeville A, Bouet V, Haelewyn B, Boulouard M, Schumann-Bard P, et al. Object recognition test in mice. Nat Protoc. 2013;8(12):2531–7.
Article
CAS
PubMed
Google Scholar
Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–58.
Article
PubMed
PubMed Central
Google Scholar
Choi TS, Lee HJ, Han JY, Lim MH, Kim HI. Molecular insights into human serum albumin as a receptor of amyloid-β in the extracellular region. J Am Chem Soc. 2017;139(43):15437–45.
Article
CAS
PubMed
Google Scholar
Araujo DM, Cotman CW. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer’s disease. Brain Res. 1992;569(1):141–5.
Article
CAS
PubMed
Google Scholar
Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS. Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer’s disease. J Neurosci Res. 2011;89(6):808–14.
Article
CAS
PubMed
Google Scholar
Mercuriali F, Inghilleri G. Albumin: is it a play-maker, a carrier or both? Anaesthesia, Pain, Intensive Care and Emergency Medicine — APICE; 1999. Milano: Springer Milan; 1999.
Google Scholar
Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev. 1995;20(3):269–87.
Article
CAS
PubMed
Google Scholar
Ahn SM, Byun K, Cho K, Kim JY, Yoo JS, Kim D, et al. Human microglial cells synthesize albumin in brain. Plos One. 2008;3(7):e2829.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhou R, Shi XY, Bi DC, Fang WS, Wei GB, Xu X. Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of β-amyloid. Mar Drugs. 2015;13(9):5828–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang BY, Zhong Y, Zhao Z, Miao Y. Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils. Pharmacol Biochem Behav. 2014;126:83–9.
Article
CAS
PubMed
Google Scholar
Rumbaugh G, Sillivan SE, Ozkan ED, Rojas CS, Hubbs CR, Aceti M, et al. Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue. Neuropsychopharmacology. 2015;40(10):2307–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prasad H, Rao R. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc Natl Acad Sci U S A. 2018;115(28):E6640–E9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janczura KJ, Volmar CH, Sartor GC, Rao SJ, Ricciardi NR, Lambert G, et al. Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proc Natl Acad Sci U S A. 2018;115(47):E11148–E57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang L, Liu C, Wu J, Tao JJ, Sui XL, Yao ZG, et al. Tubastatin A/ACY-1215 improves cognition in Alzheimer’s disease transgenic mice. J Alzheimers Dis. 2014;41(4):1193–205.
Article
CAS
PubMed
Google Scholar
Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology. Brain. 2016;139(Pt 3):891–907.
Article
PubMed
PubMed Central
Google Scholar
Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer’s disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol. 1993;52(6):594–600.
Article
CAS
PubMed
Google Scholar
Wu N, Zhu Y, Xu X, Zhu Y, Song Y, Pang L, et al. The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma. J Cancer. 2018;9(6):987–97.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhang J, Ng S, Wang J, Zhou J, Tan SH, Yang N, et al. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. Autophagy. 2015;11(4):629–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tian Y, Ding W, Wang Y, Ji T, Sun S, Mo Q, et al. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters. Plos One. 2013;8(12):e84457.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging. 2008;29(11):1607–18.
Article
CAS
PubMed
Google Scholar
Zhang Y, Lee DH. Sink hypothesis and therapeutic strategies for attenuating abeta levels. Neuroscientist. 2011;17(2):163–73.
Article
CAS
PubMed
Google Scholar
Liu YH, Wang YR, Xiang Y, Zhou HD, Giunta B, Manucat-Tan NB, et al. Clearance of amyloid-beta in Alzheimer’s disease: shifting the action site from center to periphery. Mol Neurobiol. 2015;51(1):1–7.
Article
PubMed
CAS
Google Scholar
DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-Abeta antibody alters CNS and plasma Abeta clearance and decreases brain Abeta burden in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2001;98(15):8850–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Gool B, Storck SE, Reekmans SM, Lechat B, Gordts P, Pradier L, et al. LRP1 has a predominant role in production over clearance of Aβ in a mouse model of Alzheimer’s disease. Mol Neurobiol. 2019;56(10):7234–45.
Article
PubMed
PubMed Central
CAS
Google Scholar
Storck SE, Meister S, Nahrath J, Meissner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier. J Clin Invest. 2016;126(1):123–36.
Article
PubMed
Google Scholar
Kanekiyo T, Cirrito JR, Liu CC, Shinohara M, Li J, Schuler DR, et al. Neuronal clearance of amyloid-β by endocytic receptor LRP1. J Neurosci. 2013;33(49):19276–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43(3):333–44.
Article
CAS
PubMed
Google Scholar
Wilhelmus MM, de Waal RM, Verbeek MM. Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer’s disease. Mol Neurobiol. 2007;35(3):203–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem. 1996;271(51):32916–22.
Article
CAS
PubMed
Google Scholar
Hamashima Y, Harter JG, Coons AH. The localization of albumin and fibrinogen in human liver cells. J Cell Biol. 1964;20(2):271–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hassan M, Azzazy E, Christenson RH. All about albumin: biochemistry, genetics, and medical applications. Theodore Peters, Jr. San Diego, CA: Academic Press, 1996, 432 pp, $85.00. ISBN 0-12-552110-3. Clin Chem. 1997;43(10):2014a–5.
Article
Google Scholar
Tilghman SM, Belayew A. Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci U S A. 1982;79(17):5254–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yuan X, Russell T, Wood G, Desiderio DM. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis. 2002;23(7–8):1185–96.
Article
CAS
PubMed
Google Scholar
Interewicz B, Olszewski WL, Leak LV, Petricoin EF, Liotta LA. Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach. Lymphology. 2004;37(2):65–72.
CAS
PubMed
Google Scholar
Celis JE, Gromov P, Cabezon T, Moreira JM, Ambartsumian N, Sandelin K, et al. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics. 2004;3(4):327–44.
Article
CAS
PubMed
Google Scholar
Ahn SM, Simpson RJ. Body fluid proteomics: prospects for biomarker discovery. Proteomics Clin Appl. 2007;1(9):1004–15.
Article
CAS
PubMed
Google Scholar
Garcovich M, Zocco MA, Gasbarrini A. Clinical use of albumin in hepatology. Blood Transfus. 2009;7:268–77.
PubMed
PubMed Central
Google Scholar
Evans TW. Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16(Suppl 5):6–11.
Article
CAS
PubMed
Google Scholar
Kim TS, Pae CU, Yoon SJ, Jang WY, Lee NJ, Kim JJ, et al. Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2006;21(4):344–8.
Article
PubMed
Google Scholar
Zhong X, Liao Y, Chen X, Mai N, Ouyang C, Chen B, et al. Abnormal serum bilirubin/albumin concentrations in dementia patients with abeta deposition and the benefit of intravenous albumin infusion for Alzheimer’s disease treatment. Front Neurosci. 2020;14:859.
Article
PubMed
PubMed Central
Google Scholar
Boada M, Anaya F, Ortiz P, Olazaran J, Shua-Haim JR, TO O, et al. Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in Alzheimer’s disease patients: a multicenter, randomized, controlled clinical trial. J Alzheimers Dis. 2017;56(1):129–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boada M, Lopez O, Nunez L, Szczepiorkowski ZM, Torres M, Grifols C, et al. Plasma exchange for Alzheimer’s disease management by albumin replacement (AMBAR) trial: study design and progress. Alzheimers Dement (N Y). 2019;5:61–9.
Article
Google Scholar
Vanhaecke T, Henkens T, Kass GE, Rogiers V. Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures. Biochem Pharmacol. 2004;68(4):753–60.
Article
CAS
PubMed
Google Scholar
Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci. 2009;29(13):4252–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Norden DM, Godbout JP. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol. 2013;39(1):19–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lucin KM, O'Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ, et al. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease. Neuron. 2013;79(5):873–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Picon-Pages P, Bonet J, Garcia-Garcia J, Garcia-Buendia J, Gutierrez D, Valle J, et al. Human albumin impairs amyloid beta-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in Alzheimer’s disease. Comput Struct Biotechnol J. 2019;17:963–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tomioka T, Maruoka H, Kawa H, Yamazoe R, Fujiki D, Shimoke K, et al. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. Neurosci Res. 2014;88:39–48.
Article
CAS
PubMed
Google Scholar